Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1.09B
-
Number of holders
-
214
-
Total 13F shares, excl. options
-
54.2M
-
Shares change
-
+532K
-
Total reported value, excl. options
-
$7.22B
-
Value change
-
+$70.2M
-
Put/Call ratio
-
0.92
-
Number of buys
-
133
-
Number of sells
-
-67
-
Price
-
$133.43
Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q1 2021
240 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q1 2021.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 214 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.2M shares
of 1.09B outstanding shares and own 4.97% of the company stock.
Largest 10 shareholders include Capital World Investors (8.38M shares), BAILLIE GIFFORD & CO (3.87M shares), BlackRock Inc. (3.73M shares), FMR LLC (3.38M shares), BRILLIANCE ASSET MANAGEMENT LTD (2.92M shares), VANGUARD GROUP INC (2.44M shares), WELLINGTON MANAGEMENT GROUP LLP (2.1M shares), FEDERATED HERMES, INC. (1.98M shares), BAMCO INC /NY/ (1.82M shares), and CREDIT SUISSE AG/ (1.74M shares).
This table shows the top 214 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.